Microgravity Platforms for Biotechnology
Creating a new knowledge-intensive industry at the interface between aerospace and biotechnology in Aotearoa New Zealand
Growing protein crystals in space to benefit humanity
Our five year research programme is developing fully automated and high-throughput protein crystallisation platforms that launch to space and fly on the International Space Station.
We understand the vital role protein structures play in discovering the medicines of the future.
Superior Quality Crystals
The microgravity environment of Low Earth Orbit is uniquely suited to growing higher quality and larger protein crystals than can be grown on Earth, where gravity and convective forces disrupt crystal growth.
For Drug Discovery
The protein crystals will return to Earth for analysis in synchrotrons to determine the detailed protein structure – which is key for development of future medicines and vaccines.
Fully Automated
Our payload platform will be fully automated once installed on the space station, cycling protein crystal experiments through a series of imagers to monitor growth.
High Throughput
As well as automation, our platform is able to process large numbers of protein experiments using proprietary microfluidic technology.
Our Kiwi ingenuity and world-class science are innovating a new high-tech industry in Aotearoa New Zealand
Leaving an indelible mark on the landscape of tomorrow.
An expert team
Our science and engineering team is built from the best
University of Canterbury
- Protein Biochemistry
- Microfluidics & Nanofabrication
- Space Systems Engineering
University of Auckland
- Te Whai Ao Dodd-Walls Centre
- Advanced Optics
- Photonic and Quantum Technologies
Asteria Engineering
- Hardware Engineering
- Electronics Experts
- Space Systems Engineering
Intranel
- Control System Engineering
- Software Development
- Customer Interface
Axiom Space
- Launch Vehicle Interface
- Microgravity Science
- Commercial Space
Funded by Aotearoa New Zealand’s Ministry of Business, Innovation & Employment
“This initial project represents just the beginning of what we hope to develop into an entirely new industry in New Zealand at the interface between aerospace and biotechnology.”
Dr Sarah Kessans
Principal Investigator
Questions?
Get in touch